Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Aug 03, 2026
Lam Research (LRCX) Shares Drop -20.4% Over 30 Days Amid Semiconductor Equipment Selloff

Lam Research (LRCX) Shares Drop -20.4% Over 30 Days Amid Semiconductor Equipment Selloff

Key Takeaways

  • Lam Research (LRCX) shares have fallen approximately 20.4% over the past 30 days, dropping from $351.41 on July 2 to $279.66 as of August 3, 2026.
  • A broader semiconductor equipment sector selloff, profit-taking after a massive year-to-date rally, and mounting valuation concerns have driven the steep decline.
  • The stock's fourth-quarter fiscal 2026 results, released July 29, exceeded analyst expectations with revenue of $6.72 billion and non-GAAP EPS of $1.82, yet the positive earnings surprise failed to halt the downward momentum.
  • Management raised its 2026 wafer fabrication equipment spending outlook to the low-$150-billion range and guided September-quarter revenue to $8.1 billion, underscoring strong underlying business fundamentals.
  • Key risks weighing on sentiment include China export-control uncertainty, uneven NAND and DRAM spending patterns, and broader questions about whether AI infrastructure investment can sustain current valuations.
  • The stock has now retreated more than 36% from its 52-week high of $438.50 reached on June 30, 2026.

Company Overview and Market Position

Lam Research Corporation is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Headquartered in Fremont, California, the company designs and manufactures systems used in thin film deposition, plasma etch, and wafer cleaning — processes essential to producing advanced integrated circuits. Nearly every advanced semiconductor chip is built with Lam technology. The company's equipment is embedded in the production workflows of leading foundries, memory manufacturers, and integrated device makers including TSM, Samsung, INTC, and MU. Lam holds a leading market share in etch and a significant position in deposition, while its Customer Support Business Group generates recurring revenue from an installed base exceeding 100,000 chambers worldwide. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Stock Price Performance Over the Last 30 Days and Quarter

Over the last 30 days, LRCX shares have recorded a pronounced decline of roughly 20.4%, falling from a closing price of $351.41 on July 2, 2026, to approximately $279.66 as of August 3. The selloff accelerated through mid-to-late July, with the stock breaking decisively below its 50-day moving average and touching an intraday low of $250.50 on July 29 before a brief bounce following earnings.

Zooming out to the full quarter, the picture is more nuanced. Approximately 90 days ago, in early May 2026, LRCX traded near $258. From that base, the stock staged a powerful rally into late June, peaking at $438.50 on June 30 — a gain of roughly 70% in less than two months. However, the entire advance unwound in July, leaving the stock up only about 8% over the broader quarterly period despite the dramatic round-trip. This pattern highlights both the extreme momentum that characterized semiconductor equipment names during the first half of 2026 and the speed with which sentiment has reversed.

Drivers Behind the Recent 30-Day Decline

The 20.4% decline in LRCX shares during the last 30 days has been driven primarily by a sector-wide de-risking event rather than company-specific fundamental deterioration. As the broader semiconductor group entered bear-market territory in July, investors aggressively rotated out of high-multiple equipment names that had delivered outsized year-to-date gains. LRCX had surged more than 100% year-to-date by late June, making it a prime target for profit-taking once sentiment shifted. I also checked this using Tickeron’s AI Pattern Search Engine to see how the stock compares to others in the industry.

Macro-level concerns compounded the pressure. TSM's July 16 announcement raising its 2026 capital spending outlook to $60–$64 billion came paired with a warning that overseas expansion costs and 2-nanometer ramp expenses would pressure second-half margins — reinforcing unease that rising chip investment may not translate cleanly into equipment-sector earnings. Growing investor scrutiny of Big Tech's AI capital spending, highlighted by multiple media reports questioning whether hyperscaler investments would generate adequate returns, added another layer of caution.

Lam Research's own Q4 fiscal 2026 earnings report on July 29 illustrated the disconnect between fundamentals and price action. The company delivered revenue of $6.72 billion and non-GAAP EPS of $1.82, both exceeding consensus estimates. NAND revenues more than doubled sequentially, the Customer Support Business Group posted its third consecutive record quarter, and management raised its calendar 2026 wafer fabrication equipment spending forecast to the low-$150-billion range. Guidance for the September quarter called for revenues of $8.1 billion at the midpoint. Despite those strong numbers, the stock sold off further, indicating that near-term price action is being driven by macro sentiment and technical factors rather than operating performance.

Performance Over the Past Quarter

Lam Research's quarterly performance tells a story of two distinct phases. The rally from early May through late June reflected genuine enthusiasm around AI-driven semiconductor demand. The company's March-quarter results set the tone: revenue of $5.84 billion rose 24% year-over-year, non-GAAP EPS of $1.47 jumped 41%, and management raised its WFE outlook from $135 billion to $140 billion. Multiple Wall Street analysts lifted price targets, with firms including Stifel, Mizuho, TD Cowen, and Cantor Fitzgerald issuing targets ranging from $400 to $500. The company also benefited from strong advanced packaging momentum, with management forecasting over 50% growth in that segment for calendar 2026.

The July reversal, however, erased those gains as the market's tolerance for premium valuations contracted sharply. At its June peak, LRCX traded at a forward P/E above 40, well above the industry average. China export-control uncertainty, uneven memory spending patterns, and insider selling activity — including a director's $6.12 million stock sale in mid-July — contributed to the deteriorating sentiment. By early August, the stock had surrendered virtually all the ground gained since mid-May, underscoring the high-beta nature of semiconductor equipment names in a risk-off environment.

Key Factors to Watch Going Forward

Several factors are likely to shape Lam Research's stock trajectory in the coming months. The September-quarter earnings report will be closely watched to see whether the company can sustain its momentum, particularly given the ambitious $8.1 billion revenue guidance. Execution on the NAND recovery — where revenues more than doubled sequentially in the June quarter — remains critical, as does continued strength in advanced packaging, which management expects to grow over 70% year-over-year in calendar 2026.

On the macro front, China export-control developments remain a persistent overhang. Any tightening of restrictions could directly impact Lam's revenue visibility given that China represented 26% of total revenue in the June quarter. Conversely, stabilization or easing of trade tensions could provide a meaningful catalyst. The trajectory of AI infrastructure spending by major hyperscalers will also be pivotal; any slowdown in capacity expansion plans could pressure the entire semiconductor equipment complex. Additionally, with the stock now trading well below analyst consensus price targets — which averaged around $351 to $361 prior to the selloff — investors will be watching for analyst revisions and whether the fundamental story can eventually reassert itself over macro-driven sentiment.

Exploring AI-Powered Trading Insights

From what I see, tools like Tickeron’s Trending AI Robots can help investors spot patterns across automated strategies. The page highlights top-performing bots with consistent metrics across different timeframes and risk levels, offering a way to align data-driven approaches with specific trading goals without replacing personal analysis.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: LRCX

LRCX's RSI Indicator climbs out of oversold territory

The RSI Indicator for LRCX moved out of oversold territory on July 30, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 18 similar instances when the indicator left oversold territory. In of the 18 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 07, 2026. You may want to consider a long position or call options on LRCX as a result. In of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LRCX just turned positive on August 05, 2026. Looking at past instances where LRCX's MACD turned positive, the stock continued to rise in of 59 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LRCX advanced for three days, in of 325 cases, the price rose further within the following month. The odds of a continued upward trend are .

LRCX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

LRCX moved below its 50-day moving average on July 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for LRCX crossed bearishly below the 50-day moving average on July 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LRCX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LRCX entered a downward trend on August 07, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LRCX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: LRCX's P/B Ratio (33.784) is very high in comparison to the industry average of (9.013). P/E Ratio (58.509) is within average values for comparable stocks, (176.968). Projected Growth (PEG Ratio) (1.568) is also within normal values, averaging (1.654). Dividend Yield (0.003) settles around the average of (0.006) among similar stocks. P/S Ratio (18.282) is also within normal values, averaging (38.579).

Notable companies

The most notable companies in this group are Applied Materials (NASDAQ:AMAT), Lam Research Corp (NASDAQ:LRCX), KLA Corporation (NASDAQ:KLAC), Teradyne (NASDAQ:TER), Ambarella (NASDAQ:AMBA).

Industry description

The electronic production equipment industry makes equipment used to produce semiconductors. Such equipment includes wafer fabrication, plasma etching and photo-resist processing equipment. The industry also makes chemical vapor deposition processing systems and photomasks, which are high-purity quartz plates that contain patterns to define integrated circuits layouts. Applied Materials, Inc., Lam Research Corporation, and KLA-Tencor Corporation are examples of electronic production equipment manufacturing companies.

Market Cap

The average market capitalization across the Electronic Production Equipment Industry is 67.85B. The market cap for tickers in the group ranges from 555.66K to 694.76B. ASML holds the highest valuation in this group at 694.76B. The lowest valued company is AVSR at 555.66K.

High and low price notable news

The average weekly price growth across all stocks in the Electronic Production Equipment Industry was 7%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 46%. ONTO experienced the highest price growth at 26%, while SMTK experienced the biggest fall at -28%.

Volume

The average weekly volume growth across all stocks in the Electronic Production Equipment Industry was 1%. For the same stocks of the Industry, the average monthly volume growth was 0% and the average quarterly volume growth was -64%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 64
P/E Growth Rating: 32
Price Growth Rating: 44
SMR Rating: 74
Profit Risk Rating: 60
Seasonality Score: -25 (-100 ... +100)
View a ticker or compare two or three
LRCX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a manufacturer of semiconductor processing equipment

Industry ElectronicProductionEquipment

Profile
Details
Industry
Electronic Production Equipment
Address
4650 Cushing Parkway
Phone
+1 510 572-0200
Employees
19000
Web
https://www.lamresearch.com
Interact to see
Advertisement
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.
Gogo shares continue to trade near 52-week lows around $4, weighed down by competitive threats from Starlink and slower-than-anticipated AVANCE system upgrades. William Blair downgraded the stock to Market Perform in December 2025, citing leverage concerns and intensifying rivalry in in-flight connectivity.
Quantum Computing Inc. completed a $110 million acquisition of Luminar Semiconductor on February 2, significantly strengthening its photonics and manufacturing capabilities. Shares have traded with elevated volatility, peaking near $12.70 in mid-January before retreating to the $9 range amid heavy volume.
ERII shares have remained resilient, trading near $15.47 ahead of Q4 and full-year 2025 earnings scheduled for February 25, 2026. Q3 2025 results exceeded expectations, with revenue of $32 million and EPS of $0.07, despite year-over-year declines tied to project timing.
Golar LNG (GLNG) has remained resilient in recent trading, hovering near the top of its 52-week range as investor interest in floating LNG infrastructure continues to build. The stock is underpinned by a deep FLNG order backlog, steady production from operating assets, and improving financial flexibility.
Liberty Broadband Corporation (LBRDA) has experienced pronounced swings in recent weeks, touching multiyear lows before staging a sharp recovery. The stock continues to trade within a wide 52-week range, closely tied to the value of its Charter Communications stake and investor expectations around the proposed merger.
Apollo Global Management (APO), a leading alternative asset manager, reports Q4 and full-year 2025 results on February 9, 2026, before the market opens. The firm has delivered a year of strong growth, with AUM expanding on record inflows exceeding $200 billion and origination surpassing $300 billion.